Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

May 23, 2022

Conditions
COVID-19
Interventions
OTHER

Serology test follow-up

"The enrolled participants will be invited to visit ESS. They will then meet the occupational physician, who wil obtain their free, informed and written consent. The information and consent will be recorded in the personal medical follow-up file.The staff will then complete the self-questionnaire and the ESS physician will provide a prescription for the blood samples to be taken.~In case of positive answers to one or more of the questions in this self-questionnaire, the enrolled participant will be contacted in order to schedule another post-COVID-19 consultation with additional examinations if needed (new COVID PCR, scanner, etc.)."

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint-Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT04488484 - Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. | Biotech Hunter | Biotech Hunter